UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effectiveness and safety of 1-L PEG-ASC versus other bowel preparations for colonoscopy: A meta-analysis of nine randomized clinical trials

Digestive and liver disease, 2023-08, Vol.55 (8), p.1010-1018

2023

Volltextzugriff (PDF)

A SCAN-TO-BIM PROCESS FOR THE MONITORING AND CONSERVATION OF THE ARCHITECTURAL HERITAGE: INTEGRATION OF THEMATIC INFORMATION IN A HBIM MODEL

International archives of the photogrammetry, remote sensing and spatial information sciences., 2023, Vol.XLVIII-M-2-2023, p.549-556

2023

Volltextzugriff (PDF)

Corrigendum to “Effectiveness and safety of 1-L PEG-ASC versus other bowel preparations for colonoscopy: A meta-analysis of nine randomized clinical trials” [Digestive and Liver Disease, Volume 55, Issue 8, August 2023, Pages 1010–1018]

Digestive and liver disease, 2023-12, Vol.55 (12), p.1782-1782

2023

Volltextzugriff (PDF)

Food habits of two leopard species, competition, climate change and upper treeline: a way to the decrease of an endangered species?

Ethology, ecology & evolution, 2013-10, Vol.25 (4), p.305-318

2013

Volltextzugriff (PDF)

Effectiveness and safety of NER1006 versus standard bowel preparations: A meta-analysis of randomized phase-3 clinical trials

Digestive and liver disease, 2020-08, Vol.52 (8), p.833-839

2020

Volltextzugriff (PDF)

Human pregnancy is accompanied by modifications in B cell development and immunoglobulin profile

Journal of reproductive immunology, 2018-09, Vol.129, p.40-47

2018

Volltextzugriff (PDF)

Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2017-11, Vol.52 (11), p.1530-1536

2017

Volltextzugriff (PDF)

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.1040-1041

2018

Volltextzugriff (PDF)

OC.06.4: The Addition of an Immunosuppressant is an Effective Optimization Strategy after Loss of Response to Anti-Tnf Alpha Monotherapy in Patients with Inflammatory Bowel Disease: A Two-Year Experience

Digestive and liver disease, 2017-03, Vol.49, p.e92-e92

2017

Volltextzugriff (PDF)

Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT

Bone marrow transplantation (Basingstoke), 2015-01, Vol.50 (1), p.106-112

2015

Volltextzugriff (PDF)

P.11.15: The Long Term Course of Patients Undergoing Ileal Pouch-Anal Anastomosis for Ulcerative Colitis

Digestive and liver disease, 2017-03, Vol.49, p.e208-e208

2017

Volltextzugriff (PDF)

OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety

Digestive and liver disease, 2017-03, Vol.49, p.e91-e91

2017

Volltextzugriff (PDF)

P727 Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i857-i858

2023

Volltextzugriff (PDF)

T04.02.5 EFFECTIVENESS AND SAFETY OF USTEKINUMAB FOR THE TREATMENT OF CROHN'S DISEASE IN REAL-LIFE STUDIES: A META-ANALYSIS

Digestive and liver disease, 2020-10, Vol.52, p.S129

2020

Volltextzugriff (PDF)

T05.01.13 EFFECTIVENESS AND SAFETY OF NER1006 VERSUS STANDARD BOWEL PREPARATIONS: A META-ANALYSIS OF THREE RANDOMISED PHASE 3 CLINICAL TRIALS

Digestive and liver disease, 2020-10, Vol.52, p.S143-S144

2020

Volltextzugriff (PDF)

P308 Effectiveness and Safety of tofacitinib for the Treatment of Ulcerative Colitis: A Single-Arm Meta-analysis of Observational Studies

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S336-S336

2021

Volltextzugriff (PDF)

PW01-120 - Mental health, treatment response and utilization among Iraqi refugees as compared to non-war exposed Arab immigrants

European psychiatry, 2010, Vol.25 (S1), p.1536-1536, Article 25-E1519

2010

Volltextzugriff (PDF)

OC.09.1 LUPUS-LIKE REACTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ANTI-TNFs ARE RARE BUT INSIDIOUS ADVERSE EVENTS: DATA FROM A LARGE SINGLE-CENTER COHORT

Digestive and liver disease, 2019-03, Vol.51, p.e100-e100

2019

Volltextzugriff (PDF)

Haplotype-phased genome assembly for Ficus carica breeding

Acta horticulturae, 2022-10 (1349), p.13-18

2022

Volltextzugriff (PDF)

OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN’S DISEASE

Digestive and liver disease, 2022-05, Vol.54, p.S93-S94

2022

Volltextzugriff (PDF)

T.06.10 EFFICACY AND SAFETY OF BIOSIMILARS OF ANTI-TNF-APLHA IN PAEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD)

Digestive and liver disease, 2022-05, Vol.54, p.S141-S142

2022

Volltextzugriff (PDF)

T.10.1 SAFETY AND EFFECTIVENESS OF TOFACITINIB IN ULCERATIVE COLITIS: REAL-WORLD DATA FROM TOFA-UC, A SN-IBD STUDY

Digestive and liver disease, 2023-03, Vol.55, p.S178-S178

2023

Volltextzugriff (PDF)

OC.07.2: ASSESSMENT OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY (AVENUE) PATIENTS WITH CROHN'S DISEASE (CD): AN IG-IBD STUDY

Digestive and liver disease, 2024-04, Vol.56, p.S161-S163

2024

Volltextzugriff (PDF)

OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY

Digestive and liver disease, 2023-03, Vol.55, p.S124-S125

2023

Volltextzugriff (PDF)

T.06.2 USTEKINUMAB IS A PROMISING OPTION FOR THE TREATMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE

Digestive and liver disease, 2023-03, Vol.55, p.S159-S160

2023

Volltextzugriff (PDF)

1 – 25 von 374

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(304)
Mit Volltextzugriff
(306)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(92)
Humans
(71)
Male
(40)
Middle Aged
(38)
Female
(34)
Adult
(26)
Aged
(25)
Biological And Medical Sciences
(25)
Urology
(17)
Animals
(16)
Urology & Nephrology
(15)
Fundamental And Applied Biological Sciences. Psychology
(13)
Medical Sciences
(12)
Physical Sciences
(11)
Adolescent
(10)
Calcium - Blood
(9)
Endocrinology & Metabolism
(9)
Membrane Fluidity
(9)
Neurosciences & Neurology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Effectiveness and safety of 1-L PEG-ASC versus other bowel preparations for colonoscopy: A meta-analysis of nine randomized clinical trials

A SCAN-TO-BIM PROCESS FOR THE MONITORING AND CONSERVATION OF THE ARCHITECTURAL HERITAGE: INTEGRATION OF THEMATIC INFORMATION IN A HBIM MODEL

Corrigendum to “Effectiveness and safety of 1-L PEG-ASC versus other bowel preparations for colonoscopy: A meta-analysis of nine randomized clinical trials” [Digestive and Liver Disease, Volume 55, Issue 8, August 2023, Pages 1010–1018]

Food habits of two leopard species, competition, climate change and upper treeline: a way to the decrease of an endangered species?

Effectiveness and safety of NER1006 versus standard bowel preparations: A meta-analysis of randomized phase-3 clinical trials

Human pregnancy is accompanied by modifications in B cell development and immunoglobulin profile

Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab

OC.06.4: The Addition of an Immunosuppressant is an Effective Optimization Strategy after Loss of Response to Anti-Tnf Alpha Monotherapy in Patients with Inflammatory Bowel Disease: A Two-Year Experience

Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT

P.11.15: The Long Term Course of Patients Undergoing Ileal Pouch-Anal Anastomosis for Ulcerative Colitis

OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety

P727 Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies

T04.02.5 EFFECTIVENESS AND SAFETY OF USTEKINUMAB FOR THE TREATMENT OF CROHN'S DISEASE IN REAL-LIFE STUDIES: A META-ANALYSIS

T05.01.13 EFFECTIVENESS AND SAFETY OF NER1006 VERSUS STANDARD BOWEL PREPARATIONS: A META-ANALYSIS OF THREE RANDOMISED PHASE 3 CLINICAL TRIALS

P308 Effectiveness and Safety of tofacitinib for the Treatment of Ulcerative Colitis: A Single-Arm Meta-analysis of Observational Studies

PW01-120 - Mental health, treatment response and utilization among Iraqi refugees as compared to non-war exposed Arab immigrants

OC.09.1 LUPUS-LIKE REACTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ANTI-TNFs ARE RARE BUT INSIDIOUS ADVERSE EVENTS: DATA FROM A LARGE SINGLE-CENTER COHORT

Haplotype-phased genome assembly for Ficus carica breeding

OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN’S DISEASE

T.06.10 EFFICACY AND SAFETY OF BIOSIMILARS OF ANTI-TNF-APLHA IN PAEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD)

T.10.1 SAFETY AND EFFECTIVENESS OF TOFACITINIB IN ULCERATIVE COLITIS: REAL-WORLD DATA FROM TOFA-UC, A SN-IBD STUDY

OC.07.2: ASSESSMENT OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY (AVENUE) PATIENTS WITH CROHN'S DISEASE (CD): AN IG-IBD STUDY

OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY

T.06.2 USTEKINUMAB IS A PROMISING OPTION FOR THE TREATMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE

Suchergebnisse filtern